Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» pancreatic cancer
pancreatic cancer
Apexigen's CD40 agonist shows response in pancreatic cancer
BioCentury
Mon, 04/1/19 - 10:41 am
Apexigen
APX005M
Opdivo
pancreatic cancer
Celgene’s Abraxane Fails to Hit the Mark in a Phase III Pancreatic Cancer Study
BioSpace
Wed, 03/13/19 - 12:17 pm
Celgene
Abraxane
clinical trials
pancreatic cancer
AstraZeneca, Merck notch another major Lynparza trial win — this time in pancreatic cancer
Endpoints
Tue, 02/26/19 - 09:34 am
AstraZeneca
Merck
pancreatic cancer
clinical trials
BRCA-mutated prostate cancer
Johnson & Johnson, AbbVie superstar Imbruvica flunks pancreatic cancer test
Fierce Pharma
Mon, 01/21/19 - 10:54 am
AbbVie
JNJ
Imbruvica
pancreatic cancer
clinical trials
The Demise Of A Once Promising Pancreatic Cancer Drug Is All Too Common
Forbes
Tue, 01/15/19 - 10:01 am
pancreatic cancer
drug development
Harvard
GSK pancreatic cancer drug heads to phase 1 combo with Merck's Keytruda after positive mouse trial
Fierce Biotech
Mon, 11/12/18 - 11:47 pm
GSK
GSK095
Merck
Keytruda
pancreatic cancer
New Study Suggests Tumor Treating Fields Can Increase Progression-Free Survival in Pancreatic Cancer
CP Wire
Mon, 10/22/18 - 10:09 am
Novocure
pancreatic cancer
New Study Suggests Tumor Treating Fields Can Increase Progression-Free Survival in Pancreatic Cancer
Mon, 10/22/18 - 09:47 am
Novocure
pancreatic cancer
AstraZeneca, Merck’s Lynparza gets FDA ODD for pancreatic cancer
Pharmaceutical Business Review
Wed, 10/17/18 - 09:11 am
AstraZeneca
Merck
Lynparza
FDA
pancreatic cancer
orphan drug
Seattle Genetics Doses First Patient In Ph II Trial of Antibody-drug Conjugate in Multiple Solid Tumors
CP Wire
Thu, 07/12/18 - 09:17 am
Seattle Genetics
colorectal cancer
non-small cell lung cancer
pancreatic cancer
head and neck cancer
cervical cancer
tisotumab vedotin
Genmab
clinical trials
Pancreatic cancer study failure cripples a Merrimack drug, forcing a coup de grâce and pipeline retreat
Endpoints
Mon, 06/25/18 - 09:24 am
pancreatic cancer
MM-141
Merrimack Pharmaceuticals
Researchers at UC San Diego Developing Blood Test for Early Pancreatic Cancer Detection
CP Wire
Wed, 05/23/18 - 10:30 pm
pancreatic cancer
diagnostics
biomarkers
Researchers at UC San Diego Developing Blood Test for Early Pancreatic Cancer Detection
Wed, 05/23/18 - 01:06 pm
pancreatic cancer
Pancreatic cancer combo sees high survival rates in ChemoCentryx PhIb data
Endpoints
Tue, 01/23/18 - 02:48 pm
pancreatic cancer
ChemoCentryx
CCX872
Novocure wins FDA nod for pivotal pancreatic cancer trial
Drug Delivery Business News
Mon, 12/18/17 - 11:24 am
Novocure
FDA
pancreatic cancer
TTFields
A Pill Might Control Pancreatic Cancer, Even If It Doesn't Cure It
Forbes
Mon, 09/11/17 - 09:16 am
pancreatic cancer
PARP inhibitors
Clovis Oncology
Rubraca
The Fastest Growing Cancer Company You've Never Heard Of
Motley Fool
Thu, 07/13/17 - 09:03 am
devices
Novocure
tumor treating fields
cancer
TTFields
glioblastoma
ovarian cancer
pancreatic cancer
lung cancer
OncoMed's pancreatic cancer drug fails mid-stage study
Yahoo/Reuters
Mon, 04/10/17 - 11:00 am
OncoMed
pancreatic cancer
clinical trials
Celgene
Abraxane
demcizumab
France's Ipsen to buy Merrimack's pancreatic cancer drug, assets in $1 bln deal
Yahoo/Reuters
Mon, 01/9/17 - 09:54 am
Ipsen
France
Merrimack Pharmaceuticals
pancreatic cancer
Onivyde
Halozyme Cancer Drug Does Well in Phase 2
Investopedia
Fri, 01/6/17 - 10:13 am
Halozyme
pancreatic cancer
clinical trials
PEGPH20
Eli Lilly
Celgene
gemcitabine
Abraxane
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »